openPR Logo
Press release

Venetoclax API Market: Size, Share, Growth, Analysis, Key Players, Revenue, Growth | Valuates Reports

01-12-2024 09:12 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Valuates Reports

Venetoclax API Market
Venetoclax(CAS:1257044-40-8) is an oral selective BCL-2 inhibitor and antineoplastic agent used in the therapy of refractory chronic lymphocytic leukemia (CLL).
The global Venetoclax API market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-12G11851/Global_Venetoclax_API_Market_Research_Report_2022

North American market for Venetoclax API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Venetoclax API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Venetoclax API include Aarti Industries Limited, Dr. Reddy's Laboratories, Beijing Mesochem Technology, Hetero Drugs, Hikma Pharmaceuticals, Laurus Labs, Mylan, Teva and Transo-Pharm USA LLC, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Venetoclax API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Venetoclax API.
The Venetoclax API market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Venetoclax API market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Venetoclax API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Get regional report
https://reports.valuates.com/request/regional/QYRE-Auto-12G11851/Global_Venetoclax_API_Market_Research_Report_2022

Segment by Type
• Above 98 %
• Above 99 %

Segment by Application
• Tablets
• Others

By Company
Aarti Industries Limited, Dr. Reddy's Laboratories, Beijing Mesochem Technology, Hetero Drugs, Hikma Pharmaceuticals, Laurus Labs, Mylan, Teva, Transo-Pharm USA LLC, Veranova, LEBSA, Alembic Pharmaceuticals Limited, Changzhou Pharmaceutical Factory

View full report

https://reports.valuates.com/market-reports/QYRE-Auto-12G11851/global-venetoclax-api

Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Venetoclax API Market: Size, Share, Growth, Analysis, Key Players, Revenue, Growth | Valuates Reports here

News-ID: 3350278 • Views:

More Releases from Valuates Reports

Functional Packaging Coatings Market Share Driven by Food Safety and Pharmaceuti …
Functional Packaging Coatings Market Size The global Functional Packaging Coatings market was valued at US$ 1004 million in 2023 and is anticipated to reach US$ 1387 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030. View sample report https://reports.valuates.com/request/sample/QYRE-Auto-36A18471/Global_Functional_Packaging_Coatings_Market_Research_Report_2024 The Functional Packaging Coatings market is experiencing robust market growth as industries increasingly demand protective, durable, and sustainable coatings for packaging applications. Market trends highlight rising adoption of functional coatings that
Advertising Management Platform Market Share Driven by Digital Marketing Expansi …
Advertising Management Platform Market Size The global Advertising Management Platform market is projected to grow from US$ 2633 million in 2024 to US$ 4319.5 million by 2030, at a Compound Annual Growth Rate (CAGR) of 8.6% during the forecast period. View sample report https://reports.valuates.com/request/sample/QYRE-Auto-2Q2912/Global_Advertising_Management_Platform_Market_Insights_Forecast_to_2028 The Advertising Management Platform market is experiencing significant market growth as businesses increasingly adopt digital marketing strategies to reach diverse audiences efficiently. Market trends highlight rising demand for integrated solutions
Treat Dispensing Toys Market Share Driven by Pet Ownership Growth and Interactiv …
Treat Dispensing Toys Market Treat dispensing toys are specially designed toys that dispense small treats or dry food as your pet plays with them. These toys come in a variety of shapes, sizes, and designs, each offering different levels of difficulty and challenges to keep your pet engaged. The global Treat Dispensing Toys market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a
Legal Advisory Service Market Share Driven by Corporate Compliance and Personal …
Legal Advisory Service Market The global market for Legal Advisory Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period. View sample report https://reports.valuates.com/request/sample/QYRE-Auto-3J6143/Global_Legal_Advisory_Service_Market_Insights_Forecast_to_2028 The Legal Advisory Service market is experiencing steady market growth as businesses and individuals increasingly seek professional guidance to navigate complex regulatory, civil, and commercial frameworks. Market trends

All 5 Releases


More Releases for Venetoclax

Venetoclax Impurity Standards: A Tool for Enhanced Characterization of Degradati …
April 15, 2025 - Pune, India |Venetoclax, an essential pharmaceutical innovation in the treatment of leukemia, has emerged as a critical therapeutic for addressing chronic and acute blood cancer conditions. With its growing role in life-saving cancer therapies, the development and study of Venetoclax Impurity Standards have become imperative to ensuring pharmaceutical quality, efficacy, and safety. To know more about Venetoclax Impurity https://aquigenbio.com/products/impurity-standards/venetoclax/ To meet the increasing demand for reliable and high-quality anti-leukemia
Myelodysplastic Syndrome Clinical Trials Assessment 2024: FDA Approvals, Pipelin …
(Albany, USA) Myelodysplastic Syndrome companies are Novartis, Syros Pharmaceuticals, Curis, Ryvu Therapeutics, Chia Tai Tianqing Pharmaceutical Group, Amgen, Sanofi, Forma Therapeutics, Agios Pharmaceuticals, AbbVie, Daiichi Sankyo Company, Geron Corporation, Astex Pharmaceuticals, Jazz Pharmaceuticals, Maxinovel Pty., Ltd., Mabwell (Shanghai) Bioscience Co., Ltd., BeiGene, Ellipses Pharma, Treadwell Therapeutics, Bellicum Pharmaceuticals, and others. DelveInsight's, "Myelodysplastic Syndrome Pipeline Insight 2024" report provides comprehensive insights about 120+ companies and 150+ pipeline drugs in Myelodysplastic Syndrome pipeline
Venetoclax Market Dynamic Growth Factors, COVID-19 impact on Industry Share and …
Venetoclax Market Industry Overview: The report on the Venetoclax Market is exhaustively prepared with a main focus on the competitive geography, geographical growth, segmentation, and request dynamics, including motorists, conditions, and openings. It sheds light on crucial product, profit, and consumption trends so that players could ameliorate their deals and growth in the Global Venetoclax Market. It offers a detailed analysis of the competition and leading companies in the global Venetoclax
Venetoclax Market size, Witness Highest Growth in near future by 2026|AbbVie Inc …
Venetoclax Industry Analysis Report 2021-2026 Los Angeles, USA, Global News : Source: Straits Research – Global Venetoclax Market Review 2021 Forecast to 2029 – Analysis by Type, Application, End-User, Industry Vertical, and Region’ into its vast depository of research reports. Top Industry Players Overview: AbbVie Inc., F. Hoffmann-La Roche Ltd, and Sumitomo Dainippon Pharma Co., Ltd. Venetoclax is an antineoplastic agent used in combination with chemotherapy. The drug is used in the
Venetoclax Market Business Status and Industrial Outlook, Major Keyplayers - Abb …
Venetoclax Market 2021 Venetoclax is an antineoplastic agent used in combination with chemotherapy. The drug is used in the treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. In May 2019, the U.S. FDA approved Veneclexta (venetoclax) for treating chronic lymphocytic leukemia (CLL). To extend the use of the drug into other hematological cancer, many players like Roche's Genentech unit are collaborating with different companies on Venclexta's development. As the drug
Venetoclax Market Analysis, Key Players, Growth rate and Future Forecasts 2020-2 …
Venetoclax Market Research Report 2020 The Global Venetoclax Market research study provides a comprehensive 360° view and insights, outlining the major outcomes of the industry. These essential insights assist the decision-makers in formulating better business plans and make informed decisions for improved profitability. Moreover, the analysis helps venture capitalists in understanding the companies with a better perspective and make aware decisions. The main objective of this market research is to help the readers